Elizabeth Trehu, Chief Medical Officer at Jounce Therapeutics, Inc. (JNCE), sold 5,298 shares at $7.00 ($36K) on 2021-01-08, disclosed to the SEC on 2021-01-11.
Open-market sale of $36k JNCE by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.76 | 2,452 | $17K | 45.4% |
| 2 | $7.00 | 2,846 | $20K | 54.6% |
| Total | $6.89 avg | 5,298 | $36K | 100% |
| Filing → |
| JNCE | SELL | 2021-03-31 | $136K | — | Filing → |
| JNCE | SELL | 2021-01-22 | $78K | — | Filing → |
| JNCE | SELL | 2020-08-18 | $10K | — | Filing → |